Global Diabetic Assays Market Growth (Status and Outlook) 2025-2031

According to this study, the global Diabetic Assays market size will reach US$ million by 2031.

Diabetes can severely damage the heart, blood vessels, eyes, kidneys and nerves. A diabetes assay is used to diagnose and monitor people at risk for developing diabetes.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

LPI (LP Information)' newest research report, the “Diabetic Assays Industry Forecast” looks at past sales and reviews total world Diabetic Assays sales in 2024, providing a comprehensive analysis by region and market sector of projected Diabetic Assays sales for 2025 through 2031. With Diabetic Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetic Assays industry.

This Insight Report provides a comprehensive analysis of the global Diabetic Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Diabetic Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetic Assays market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetic Assays and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetic Assays.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetic Assays market by product type, application, key players and key regions and countries.

Segmentation by Type:
Enzymatic Assay
Colorimetric Assay
Others

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
InSphero
Abbott Laboratories
American Laboratory Products Company
Danaher Corporation
Bio RAD laboratories
Ortho Clinical Diagnostics
Roche
Siemens
PTS Diagnostics

Please note: The report will take approximately 2 business days to prepare and deliver. Show more